431 related articles for article (PubMed ID: 18831408)
1. [pH-impedancemetry: clinical implications].
Bertolini D; Roman S; Dumonceau JM
Rev Med Suisse; 2008 Sep; 4(169):1873-4, 1876-8. PubMed ID: 18831408
[TBL] [Abstract][Full Text] [Related]
2. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
[TBL] [Abstract][Full Text] [Related]
3. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
4. Weakly acidic reflux.
Tack J; Blondeau K
Dig Dis; 2009; 27(1):58-61. PubMed ID: 19439962
[TBL] [Abstract][Full Text] [Related]
5. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
Weigt J; Kandulski A; Büsch F; Malfertheiner P
Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
[TBL] [Abstract][Full Text] [Related]
6. Review article: complete gastro-oesophageal reflux monitoring - combined pH and impedance.
Tutuian R; Castell DO
Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 2():27-37. PubMed ID: 16939430
[TBL] [Abstract][Full Text] [Related]
7. Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease.
Vela MF
Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):665-72. PubMed ID: 19072344
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
Pritchett JM; Aslam M; Slaughter JC; Ness RM; Garrett CG; Vaezi MF
Clin Gastroenterol Hepatol; 2009 Jul; 7(7):743-8. PubMed ID: 19281866
[TBL] [Abstract][Full Text] [Related]
9. Use of pH-impedance testing to evaluate patients with suspected extraesophageal manifestations of gastroesophageal reflux disease.
Malhotra A; Freston JW; Aziz K
J Clin Gastroenterol; 2008 Mar; 42(3):271-8. PubMed ID: 18223497
[TBL] [Abstract][Full Text] [Related]
10. Impedance-pH monitoring: new standard for measuring gastro-oesophageal reflux.
Bredenoord AJ
Neurogastroenterol Motil; 2008 May; 20(5):434-9. PubMed ID: 18416700
[TBL] [Abstract][Full Text] [Related]
11. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
Pohl D; Tutuian R
Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
[TBL] [Abstract][Full Text] [Related]
13. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.
Mainie I; Tutuian R; Shay S; Vela M; Zhang X; Sifrim D; Castell DO
Gut; 2006 Oct; 55(10):1398-402. PubMed ID: 16556669
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
[TBL] [Abstract][Full Text] [Related]
15. Combined esophageal multichannel intraluminal impedance and pH monitoring after repair of esophageal atresia.
Fröhlich T; Otto S; Weber P; Pilic D; Schmidt-Choudhury A; Wenzl TG; Köhler H
J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):443-9. PubMed ID: 18852636
[TBL] [Abstract][Full Text] [Related]
16. Laboratory based investigations for diagnosing gastroesophageal reflux disease.
Dolder M; Tutuian R
Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):787-98. PubMed ID: 21126694
[TBL] [Abstract][Full Text] [Related]
17. New developments in detection of gastroesophageal reflux.
Emerenziani S; Sifrim D
Curr Opin Gastroenterol; 2005 Jul; 21(4):450-3. PubMed ID: 15930987
[TBL] [Abstract][Full Text] [Related]
18. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring.
Sharma N; Agrawal A; Freeman J; Vela MF; Castell D
Clin Gastroenterol Hepatol; 2008 May; 6(5):521-4. PubMed ID: 18356117
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of symptomatic reflux episodes on Acid suppressive therapy.
Tutuian R; Vela MF; Hill EG; Mainie I; Agrawal A; Castell DO
Am J Gastroenterol; 2008 May; 103(5):1090-6. PubMed ID: 18445095
[TBL] [Abstract][Full Text] [Related]
20. Correlation between gastric pH and gastro-oesophageal reflux contents: ambulatory pH-impedance monitoring results.
Roman S; Serraj I; Damon H; Mion F
Neurogastroenterol Motil; 2007 Jul; 19(7):562-8. PubMed ID: 17593137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
